Galderma Group AG (PY3)
Munich
Closed
Aug 24, 2026
Day's Range
182.0052 wk Range
140.00Profile - PY3 - Galderma Group AG
Profile
Mic Code
XMUN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
7.67K
Galderma Group AG is a leading global dermatology company headquartered in Zug, Switzerland, founded in 1981. The company operates across three core business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio encompasses flagship brands including Dysport and Azzalure for aesthetic treatments, Restylane and Sculptra for dermal fillers and biostimulators, and consumer care products like Cetaphil and Differin for acne and skincare. The company also offers prescription medications addressing conditions such as atopic dermatitis, psoriasis, and prurigo nodularis under brands like Soolantra, Epiduo, and Nemluvio. Galderma maintains a global presence through manufacturing facilities in France, Canada, Sweden, and Brazil, combined with research and development operations across multiple countries. The company serves healthcare professionals and consumers through more than 100 countries, positioning itself as the world's largest independent dermatology company dedicated exclusively to skin health and innovation.
Profile Details
Type
Common Stock
Ceo
Dr. Flemming Ornskov M.B.A., M.D., M.P.H.
Address
Zählerweg 10
City
Zug
State
MI
Zip
6300
Country
Switzerland
Phone
41 58 455 85 92
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
